Analyst Ratings for Innate Pharma S.A. (IPHA)
IPHA Rating Summary
IPHA Price Target Summary
- Highest: $9.00 (BTIG)
- Lowest: $4.00 (Leerink)
- Average: $6.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.67 (+332.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$6.67 (+332.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/11/2026 | Leerink | Daina Graybosch | Upgrade | Outperform (Market Perform) |
4.00 (N/A) |
2.22 (1.54) |
-30.63% | Details |
| 3/11/2026 | BTIG » Updated 8/11/2026 |
Jeet Mukherjee | New Coverage | Buy (N/A) |
9.00 (8.00) |
1.64 (1.54) |
-6.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
